A condition in which the stomach empties too slowly, causing nausea, vomiting, and abdominal pain after meals.
✦ AI summary
Here's what these sources say about gastroparesis (a condition involving delayed stomach emptying):
**Understanding the condition:** A position statement from the Gastroenterological Society of Australia suggests rethinking idiopathic gastroparesis not just as a mechanical emptying problem, but as a "sensorimotor disorder" that overlaps with functional dyspepsia and eating disorders — this matters because the degree of delayed emptying often doesn't match how severe someone's symptoms (nausea, vomiting, fullness, pain) actually are, and treatments aimed only at speeding up emptying haven't worked well [12].
**Links to GLP-1 diabetes/weight-loss drugs:** Several sources report that GLP-1 receptor agonists (like liraglutide and similar medications) are associated with increased rates of gastroparesis. A large real-world study found gastroparesis risk was notably higher in patients on GLP-1 drugs compared to controls, though the overall numbers were still a small fraction of users [11]. A separate cohort study comparing GLP-1 drugs to a different diabetes medication class also found higher rates of severe motility problems (including gastroparesis) with GLP-1 drugs, though abs
This is an AI-generated summary of the sources below — not medical advice. Always talk to a doctor or pharmacist about your own situation.
NauseaVomitingBloatingEarly satietyAbdominal painWeight loss
Sarcina ventriculi: An incidental finding or a byproduct of a more concerning underlying disease?
Sarcina ventriculi is a rare, acid-resistant, carbohydrate-fermenting, Gram-positive bacterium most often reported in the setting of delayed gastric emptying or gastric stasis and obstruction. Its clinical relevance is variable, ranging from incidental colonisation to potentially severe complication…
Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework.
Incretin-based pharmacotherapies, including GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists, have transformed obesity management by producing substantial weight loss through appetite suppression, reduced energy intake, and gastrointestinal effects. These mechanisms may also modify dieta…
Ageing-driven gastrointestinal variability in Parkinson's disease: implications for oral levodopa pharmacokinetics and formulation design.
Parkinson's disease is a distinctly age-associated neurodegenerative disorder in which oral levodopa remains the therapeutic foundation, particularly in older adults. Yet with advancing age, the reliability of oral therapy progressively declines not simply due to inadequate dosing, but because agein…
Long-term outcomes in patients with postural orthostatic tachycardia syndrome with an average follow-up of over 20 years.
Postural orthostatic tachycardia syndrome (POTS) is a chronic form of orthostatic intolerance that primarily affects female patients. There are scarce data evaluating the long-term outcomes in POTS. This study sought to evaluate the long-term impacts of POTS over multiple decades in adult patients.…
Dietary fiber modification by cellulase-AP3 supplementation tailors oat digestion under elderly gastrointestinal conditions with attenuated starch hydrolysis and enhanced polyphenol bioaccessibility.
The resilient fiber matrix of oats limits nutrient release and moderates glycemic response. This study employed a dynamic in vitro stomach-intestine model to investigate how Cellulase-AP3 enzyme supplementation alters oat digestion under simulated elderly conditions. Cellulase-AP3 supplementation ca…
STS101 nasal powder as a new treatment option for acute migraine with or without aura in adults.
Although effective acute migraine therapies are available, unmet treatment needs such as nausea, vomiting, or delayed gastric emptying remain. STS101 is a novel dihydroergotamine (DHE) nasal powder designed to treat acute migraine with a simple single. A targeted PubMed and ClinicalTrials.gov search…
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.
Evidence showing the association between glucagon-like 1 (GLP-1) based therapies and severe gastrointestinal motility events is limited and possible treatment effect heterogeneity by demographic and clinical characteristics is unknown. We aimed to compare rates of severe motility-related gastrointes…
Robotic Versus Laparoscopic Pancreaticoduodenectomy: A Review of Contemporary Evidence on Surgical Outcomes and Learning Curve.
Robotic pancreaticoduodenectomy (RPD) offers technical advantages over laparoscopic pancreaticoduodenectomy (LPD), including improved dexterity, visualisation, and ergonomics. However, its clinical superiority remains uncertain. A structured narrative review supported by a systematic PubMed/MEDLINE…